Abstract
The kirromycin yield ofActinoplanes sp A8924 was improved from 30–50 mg L−1 to 350 mg L−1 by mutant selection and medium optimization. The incorporation of polystyrenic resins into the fermentations promoted a further fourfold enhancement of kirromycin productivity to 1500 mg L−1. The positive effect of resin addition appears to be due to removal of kirromycin from the fermentation broth because kirromycin's minimal inhibitory concentration against the producing strain remained atca 350 mg L−1.
Similar content being viewed by others
References
Beretta G, F Le Monnier, E Selva and F Marinelli. 1993. A novel producer of the antibiotic kirromycin belonging to the genusActinoplanes. J Antibiotics 46: 1175–1177.
Berger J, HH Leher, S Teitel, H Maehr and E Grunberg. 1973. A new antibiotic X-5108 ofStreptomyces origin. I. Production, isolation and properties. J Antibiotics 26: 15–22.
Frost BM, ME Valiant, B Weissberger and EL Dulaney. 1976. Antibacterial activity of efrotomycin. J Antibiotics 29: 1083–1091.
Frost BM, ME Valiant and EL Dulaney. 1979. Antibacterial activity of heneicomycin. J Antibiotics 32: 626–629.
Gerth K, R Jansen, G Reifenstahl, G Hofle, H Irschik, B Kunze, H Reichenbach and G Thierbach. 1983. The myxalamids, new antibiotics fromMyxococcus xanthus (myxobacterales). I. Production, physicochemical and biological properties and mechanism of action. J Antibiotics 36: 1150–1156.
Hall CC, JD Watkins and NH Georgopapadaukou. 1989. Effects of elfamycins on elongation factor Tu fromEscherichia coli andStaphylococcus aureus. Antimicrob Agents Chemother 33: 322–325.
Hsi RSP, DF Witz, J Visser, WT Stoller and CL Ditto. 1989. Synthesis of carbon-13 and carbon-14 labeled paldimycin trioodium salt. J Label Radiopharm 27: 147–165.
Jarvis BB, CA Armstrong and M Zeng. 1990. Use of resins for trichothecene production in liquid cultures. J Antibiotics 43: 1502–1504.
Kunze B, W Kohl, G Hofle and H Reichenbach. 1985. Production, isolation, physico-chemical properties of angiolam A, a new antibiotic fromAngiococcus disciformis (mixobacterales). J Antibiotics 38: 1649–1654.
Liu C-M, T Hermann and PA Miller. 1977. Feedback inhibition of the synthesis of an antibiotic: aurodox (X-5108). J Antibiotics 30: 244–251.
Marshall VP, MS Little and LE Johnson. 1981. A new process and organism for the fermentation production of volonomycin. J Antibiotics 34: 902–904.
Marshall VP, SJ McWethy, JM Sirotti and JI Cialdella. 1990. The effect of neutral resins on the fermentation production of rubradirin. J Ind Microbiol 5: 283–288.
Parmeggiani A and G Sander. 1980. Properties and action of kirromycin (mocimycin) and related antibitics. In: Topics of Antibiotics Chemistry (Sammes PG, ed), pp 159–221. Ellis Horwood, Chichester.
Parmeggiani A and GWM Swart. 1985. Mechanism of action of kirromycin-like antibiotics. Ann Rev Microbiol 39: 557–577.
Potterat O and H Zahner. 1993. Metabolic products of microorganisms. 264. Exfoliamycin and related metabolites, new naphthoquinone antibiotics fromStreptomyces exfoliatus. J Antibiotics 46: 346–349.
Shirling EB and D Gottlieb. 1966. Methods for characterization ofStreptomyces species Int J Syst Bacteriol 16: 313–340.
Steinmetz H, N Bedorf, W Trowitzsch, R Krutzfeldt, K Geth, H Reichenbach and G Hofle. 1984. Large scale isolation of myxovierescins. 3rd European Congress on Biotechnology. Vol I, pp 643–647.
Unowsky J and DC Hoppe. 1978. Increased production of the antibiotic aurodox-5108 by aurodox-resistant mutants. J Antibiotics 31: 662–666.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gastaldo, L., Marinelli, F., Acquarella, C. et al. Improvement of the kirromycin fermentation by resin addition. Journal of Industrial Microbiology 16, 305–308 (1996). https://doi.org/10.1007/BF01570039
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01570039